Content Details
S. 832 (IS) - Ensuring Pathways to Innovative Cures Act of 2025
- Category
- Bills and Statutes
- Collection
- Congressional Bills
- SuDoc Class Number
- Y 1.6:
Y 1.4/1:
- Congress Number
- 119th Congress
- Congress Session
- 1st Session
- Last Action Date Listed
- March 4, 2025
- Action
- Mr. Tillis (for himself, Mr. Budd, Mrs. Blackburn, Mr. Daines, and Mr. Lankford) introduced the following bill; which was read twice and referred to the Committee on Finance
- Bill Number
- S. 832
- Bill Version
- Introduced in Senate (IS)
- Short Title
- Ensuring Pathways to Innovative Cures Act of 2025
- Full Title
- To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
- Sponsors
- Thom Tillis(NC)
- Cosponsors
- Ted Budd (NC); Marsha Blackburn (TN); Steve Daines (MT); James Lankford (OK)
- Committees
- Committee on Finance (Standing)
- United States Code Reference
- 42 U.S.C. 1320f-1(e)(1)(A)(ii)
- Sponsor:
- Tillis, Thomas
- Committee Assignment:
- Senate Committee on Finance
| Version | Links related document details | |
|---|---|---|
| 03/04/2025 | Introduced in Senate (is) | details |
Loading...
Loading...